The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
A New Approach to Autoimmunity
Using Multi-Omic Technology to Reclassify and Improve Treatment for Autoimmune Disease
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
For full access to this article login to GEN Select now.
CerCell’s Building-Block Bioreactors
Danish Company Focuses on Configurable-Batch, Single-Use Bioreactors and Fermenters
- Denmark-based CerCell specializes in single-use bioprocess products. According to company founder and CEO Per Strobbe, the company’s expertise lies in its ability to offer fully customizable, scalable single-use bioreactors and single-use fermenters. When asked about why he thinks his company is so well positioned in the single-use market, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.